0001145549-22-001663.txt : 20220114 0001145549-22-001663.hdr.sgml : 20220114 20220114140742 ACCESSION NUMBER: 0001145549-22-001663 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211031 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 EFFECTIVENESS DATE: 20220114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: North Square Investments Trust CENTRAL INDEX KEY: 0001750821 IRS NUMBER: 462828241 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23373 FILM NUMBER: 22531488 BUSINESS ADDRESS: STREET 1: 10 SOUTH LASALLE STREET, SUITE 1925 CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: (312) 857-2160 MAIL ADDRESS: STREET 1: 10 SOUTH LASALLE STREET, SUITE 1925 CITY: CHICAGO STATE: IL ZIP: 60603 0001750821 S000067944 North Square Advisory Research Small Cap Value Fund C000217840 Class I ADVGX 0001750821 S000067945 North Square Strategic Income Fund C000217841 Class A C000217842 Class I ADVNX 0001750821 S000069691 North Square Altrinsic International Equity Fund C000222264 Class I NSIVX 0001750821 S000069692 North Square McKee Bond Fund C000222265 Class I NMKYX C000222266 Class R6 NMKBX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001750821 XXXXXXXX false false false N-1A S000067945 true S000067944 true S000069691 true S000069692 true North Square Investments Trust 811-23373 0001750821 549300K2CKCXH4E67T58 10 South LaSalle Street Suite 1925 Chicago 60603 US-IL US 312-857-2160 North Square Investments, LLC 10 South LaSalle Street Suite 1925 Chicago 60603 3128572160 Records relating to the registrant's investment adviser U.S. BANCORP FUND SERVICES, LLC 615 EAST MICHIGAN STREET MILWAUKEE 53202 18336121912 Records relating to the registrant's fund administrator, fund accountant, and transfer agent U.S. BANK NATIONAL ASSOCIATION 1555 NORTH RIVER CENTER DRIVE SUITE 302 MILWAUKEE 53212 18336121912 Records relating to the registrant's custodian Foreside Funds Distributors LLC 899 Cassatt Road 400 Berwyn Park, Suite 110 Berwyn 19312 18662516920 Records relating to the registrant's distributor Algert Global LLC 101 California Street Suite 4225 San Francisco 94111 14156757300 Records relating to the registrant's sub-adviser for the Dynamic Small Cap Fund Oak Ridge Investments, LLC 10 South LaSalle Street Suite 1900 Chicago 60603 13128571040 Records relating to the registrant's sub-adviser for the Oak Ridge Dividend Growth Fund, Oak Ridge All Cap Growth Fund, Oak Ridge Small Cap Growth Fund and Multi Strategy Fund Advisory Research Inc 180 North Stetson Avenue Suite 5500 Chicago 60601 13125651414 Records relating to the registrant's sub-adviser for the Advisory Research All Cap Value Fund Red Cedar Investment Management LLC 333 Bridge Street NW Suite 601 Grand Rapids 49504 16163786894 Records relating to the registrant's sub-adviser for the Strategic Income Fund Altrinsic Global Advisors, LLC 8 Sound Shore Drive 3rd Floor Greenwich 06830 12036610030 Records relating to the registrant's sub-adviser for the Altrinsic International Fund CSM Advisors, LLC One Gateway Center, 8th Floor Pittsburgh 15222 14125661234 Records relating to the registrant's sub-adviser for the McKee Bond Fund NSI Retail Advisors, LLC One Gateway Center, 8th Floor Pittsburgh 15222 14125661234 Records relating to the registrant's sub-adviser for the Tactical Defensive Fund, Tactical Growth Fund, and Trilogy Alternative Return Fund N N N N-1A 12 Y David B. Boon N/A N Donald J. Herrema N/A N Catherine A. Zaharis N/A N Mark Goodwin N/A Y Douglas Tyre N/A 480 E. Swedesford Road Suite 220 Wayne 19087 XXXXXX N N N N N N Compass Distributors, LLC 8-69518 000172662 N/A N N Tait, Weller & Baker LLP 00445 N/A N N N N N N N North Square Strategic Income Fund S000067945 549300CK62QE77H6G155 N 2 0 0 N/A N N N N N/A N/A N/A Rule 10f-3 (17 CFR 270.10f-3) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 17e-1 (17 CFR 270.17e-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Y Y Y Y North Square Investments, LLC 801-115238 000294355 N/A N Red Cedar Investment Management, LLC 801-79728 000170939 N/A N N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Refinitiv US LLC 213800HQORQAP68CJJ04 DE N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Bloomberg L.P. 549300B56MD0ZC402L06 N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N N N RAYMOND JAMES & ASSOCIATES INC. 8-10999 000000705 U4ONQX15J3RO8XCKE979 16438.540000000000 WELLS FARGO SECURITIES LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 3219.520000000000 COWEN EXECUTION SERVICES LLC 8-46838 000035693 5493005RJDJD18OPUP27 2473.530000000000 NOMURA SECURITIES INTERNATIONAL INC. 8-15255 000004297 OXTKY6Q8X53C9ILVV871 1249.130000000000 CATHAY SECURITIES INC. 8-39247 000021821 N/A 257.320000000000 23638.040000000000 MARKETAXESS CORPORATION 8-50727 000044542 GPSMMRI21JE7ZCVYF972 12137576.000000000000 PERSHING LLC 8-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 11583851.050000000000 SG AMERICAS SECURITIES LLC 8-66125 000128351 549300F35UE0BOM1WJ55 7355472.010000000000 CITIGROUP GLOBAL MARKETS INC. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 6693959.040000000000 J.P. MORGAN SECURITIES LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 6327308.850000000000 BOFA SECURITIES INC. 8-69787 000283942 549300HN4UKV1E2R3U73 6028133.840000000000 WELLS FARGO SECURITIES LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 5480022.760000000000 MORGAN STANLEY & CO. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 3701917.400000000000 GOLDMAN SACHS & CO. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 3348350.420000000000 BNY MELLON CAPITAL MARKETS LLC 8-35255 000017454 VJW2DOOHGDT6PR0ZRO63 3231153.820000000000 82855925.690000000000 Y 74445654.000000000000 Uncommitted 50000000.000000000000 N N N N North Square Advisory Research All Cap Value Fund S000067944 549300TVPQVYWSMZGP04 N 1 0 0 N/A N N N N N/A N/A N/A Rule 10f-3 (17 CFR 270.10f-3) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 17e-1 (17 CFR 270.17e-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Y Y Y N North Square Investments, LLC 801-115238 000294355 N/A N Advisory Research, Inc. 801-14172 000108254 N/A N N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N Bloomberg L.P. 549300B56MD0ZC402L06 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Refinitiv US LLC 213800HQORQAP68CJJ04 DE N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N N N RAYMOND JAMES & ASSOCIATES INC. 8-10999 000000705 U4ONQX15J3RO8XCKE979 873.150000000000 JEFFERIES LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 300.220000000000 DASH FINANCIAL TECHNOLOGIES LLC 8-52503 000104031 549300VYG4AYVBIDN394 274.930000000000 WEEDEN & CO.L.P. 8-37267 000016835 549300OYBLKSN8M8EW67 175.740000000000 ROBERT W. BAIRD & CO. INCORPORATED 8-497 000008158 549300772UJAHRD6LO53 242.430000000000 STEPHENS INC. 8-1927 000003496 213800LH6T9XDYZCA534 155.370000000000 KEEFE BRUYETTE & WOODS INC. 8-10888 000000481 549300OM47DQV01G4854 112.920000000000 VIRTU ITG LLC 8-44218 000029299 549300S41SMIODVIT266 77.020000000000 BTIG LLC 8-65473 000122225 549300GTG9PL6WO3EC51 44.180000000000 MERRILL LYNCH PIERCE FENNER & SMITH INCORPORATED 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 50.270000000000 2379.160000000000 ROBERT W. BAIRD & CO. INCORPORATED 8-497 000008158 549300772UJAHRD6LO53 71840.000000000000 JEFFERIES LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 11848.150000000000 83688.150000000000 Y 6172970.000000000000 Uncommitted 50000000.000000000000 N N N N North Square Altrinsic International Equity Fund S000069691 549300UI6YXXFTEM2R11 Y 1 1 0 N/A N N N N N/A N/A N/A Rule 10f-3 (17 CFR 270.10f-3) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 17e-1 (17 CFR 270.17e-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Y Y Y N North Square Investments, LLC 801-115238 000294355 N/A 2020-12-04 Altrinsic Global Advisors, LLC 801-63055 000109678 N/A N U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N Y Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N Bloomberg L.P. 549300B56MD0ZC402L06 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Refinitiv US LLC 213800HQORQAP68CJJ04 DE N Y U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Y N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N N Y SANFORD C. BERNSTEIN & CO. LLC 8-52942 000104474 549300I7JYZHT7D5CO04 11486.640000000000 J.P. MORGAN SECURITIES LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 2886.340000000000 GOLDMAN SACHS & CO. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 2783.620000000000 MERRILL LYNCH PIERCE FENNER & SMITH INCORPORATED 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 2472.920000000000 MORGAN STANLEY & CO. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 1352.990000000000 ALLEN & COMPANY LLC 8-12123 000001042 549300RO3RYDN328JY68 1352.150000000000 INSTINET LLC 8-23669 000007897 549300MGMN3RKMU8FT57 1300.030000000000 EXANE INC. 8-49569 000041784 6SDWK6FV8H98XAGSYS75 1089.770000000000 REDBURN (USA) LLC 8-67320 000140564 213800TYRTQILMQQLV79 983.330000000000 BARCLAYS CAPITAL INC. 8-41342 000019714 AC28XWWI3WIBK2824319 831.650000000000 29122.820000000000 SANFORD C. BERNSTEIN & CO. LLC 8-52942 000104474 549300I7JYZHT7D5CO04 22433.230000000000 22433.230000000000 Y 29840247.000000000000 Uncommitted 50000000.000000000000 N N N N North Square McKee Bond Fund S000069692 549300PHHMXSPZQUPF03 Y 2 2 0 N/A N N N N N/A N/A N/A Rule 10f-3 (17 CFR 270.10f-3) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 17e-1 (17 CFR 270.17e-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Y Y Y Y North Square Investments, LLC 801-115238 000294355 N/A 2020-12-28 CSM Advisors, LLC 801-117641 000306128 N/A Y U.S. Bancorp Fund Services, LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N Y Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N Bloomberg L.P. 549300B56MD0ZC402L06 N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Refinitiv US LLC 213800HQORQAP68CJJ04 DE N Y U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Y N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N N Y 0.000000000000 J.P. MORGAN SECURITIES LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 38867515.650000000000 DEUTSCHE BANK SECURITIES INC. 8-17822 000002525 9J6MBOOO7BECTDTUZW19 30901528.070000000000 CITIGROUP GLOBAL MARKETS INC. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 23337529.420000000000 WELLS FARGO SECURITIES LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 22350197.950000000000 GOLDMAN SACHS & CO. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 18403385.650000000000 NOMURA SECURITIES INTERNATIONAL INC. 8-15255 000004297 OXTKY6Q8X53C9ILVV871 16676780.590000000000 PERSHING LLC 8-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 13197011.820000000000 STONEX FINANCIAL INC. 8-51269 000045993 549300LNKU6K5TJCRG93 12617382.850000000000 RBC CAPITAL MARKETS LLC 8-45411 000031194 549300LCO2FLSSVFFR64 11155203.210000000000 BOFA SECURITIES INC. 8-69787 000283942 549300HN4UKV1E2R3U73 10236343.510000000000 243427483.020000000000 N 65188393.000000000000 Uncommitted 50000000.000000000000 N N N true INTERNAL CONTROL RPT 2 ns103121g1aiii.htm INTERNAL CONTROL LETTER

  

  

  

  

  

  

  

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

  

To the Shareholders and 

Board of Trustees of 

North Square Investments Trust 

Chicago, IL 60603 

  

  

In planning and performing our audits of the financial statements of the North Square Advisory Research All Cap Value Fund, North Square Altrinsic International Equity Fund, North Square McKee Bond Fund, and North Square Strategic Income Fund (the “Funds”), each a series of North Square Investments Trust, as of and for the year ended October 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered their internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we express no such opinion. 

  

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements. 

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

  

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. 

  

Our consideration of the Funds’ internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States).  However, we noted no deficiencies in the Funds’ internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of October 31, 2021. 

  

This report is intended solely for the information and use of management, Shareholders and Board of Trustees of North Square Investments Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

  

/s/ Tait, Weller & Baker LLP  

TAIT, WELLER & BAKER LLP 

Philadelphia, Pennsylvania 

December 30, 2021